The novel therapy of the medication represents a significant advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – providing improved sugar control and possible weight reduction. Researchers are exploring its potential effects and part in the comple